A Study to Evaluate the Efficacy and Safety of AD-208

Clinical trial NCT04825561 · COMPLETED

Trial details

NCT number: NCT04825561
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Androgenetic Alopecia

Start date: 2021-06-09
Primary completion: 2023-01-09
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.